{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:03:06Z","timestamp":1794862986931,"version":"4.9.1"},"reference-count":44,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T00:00:00Z","timestamp":1205280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\/aims: <\/jats:bold> Celiac disease (CD) is associated with primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis. We investigated the following: (i) the prevalence of tissue transglutaminase antibodies (tTGAs) and endomysial antibodies (EMAs) in end\u2010stage autoimmune liver disease (ESALD), (ii) the correlation among auto\u2010antibodies and the human leucocyte antigen (HLA) haplotype, and (iii) the effect of liver transplantation on antibody kinetics.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Pretransplantation sera from 488 patients (310 with ESALD, and 178 with non\u2010autoimmune disease) were tested for tTGAs. Positive samples were also tested for EMAs, and retested 6\u201312 and \u226524 months post\u2010transplantation. Results were correlated with the HLA type of the recipient.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Serological evidence of CD was found in 3% (ESALD) vs. 0.6% (non\u2010autoimmune) of the patients (five\u2010fold increased risk in ESALD). The prevalence of tTGAs (14.2 vs. 5.4%, <jats:italic>P<\/jats:italic>=0.0001) and EMAs (4.3 vs. 0.78%, <jats:italic>P<\/jats:italic>=0.01) was significantly higher in patients with the HLA\u2010DQ2 or HLA\u2010DQ8 haplotypes. tTGAs and EMAs normalized in 94 and 100%, respectively, without gluten exclusion post\u2010transplantation. Post\u2010transplantation, of the five patients with symptoms of \u2018classical\u2019 CD, three improved. Intestinal lymphoma was diagnosed in another two cases with clinically \u2018silent\u2019 CD.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> Patients with ESALD, especially those who are HLA\u2010DQ2 or HLA\u2010DQ8 positive had a high prevalence of CD\u2010associated antibodies. Both tTGAs and EMAs decreased post\u2010transplantation without gluten withdrawal. Immunosuppression may improve symptoms of CD, but might not prevent progression to intestinal lymphoma.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2008.01681.x","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T13:17:59Z","timestamp":1282915079000},"page":"467-476","source":"Crossref","is-referenced-by-count":39,"title":["Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation"],"prefix":"10.1111","volume":"28","author":[{"given":"Alberto","family":"Rubio\u2010Tapia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad S.","family":"Abdulkarim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell H.","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Breanndan","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia K.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.8521"},{"key":"e_1_2_7_3_2","first-page":"843","article-title":"Celiac disease genetics","volume":"3","author":"Sollid LM","year":"2005","journal-title":"current concepts and practical applications"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.53"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.10.004"},{"key":"e_1_2_7_6_2","first-page":"1","article-title":"NIH Consensus Development Conference on Celiac Disease","volume":"21","year":"2004","journal-title":"NIH Consens State Sci Statements"},{"key":"e_1_2_7_7_2","first-page":"47","article-title":"Systematic review","volume":"24","author":"Lewis NR","year":"2006","journal-title":"the use of serology to exclude or diagnose celiac disease (a comparison of the endomysial and tissue transglutaminase antibody tests)"},{"issue":"1","key":"e_1_2_7_8_2","first-page":"S38","article-title":"The diagnostic accuracy of serologic tests for celiac disease","volume":"128","author":"Rostom A","year":"2005","journal-title":"a systematic review"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010852"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.02.021"},{"key":"e_1_2_7_11_2","first-page":"515","article-title":"Systematic review","volume":"21","author":"Duggan JM","year":"2005","journal-title":"the liver in celiac disease"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310000438"},{"key":"e_1_2_7_13_2","first-page":"2472","article-title":"Anti\u2010tissue transglutaminase antibodies in patients with abnormal liver test","volume":"100","author":"LoIacono O","year":"2005","journal-title":"is it always celiac disease?"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2005.01.015"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220322"},{"key":"e_1_2_7_16_2","first-page":"959","article-title":"Hepatic damage during celiac disease in childhood","volume":"38","author":"Bonamico M","year":"1986","journal-title":"Minerva Pediatr"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11222-3"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290318"},{"key":"e_1_2_7_19_2","first-page":"736","article-title":"Risk of primary biliary liver cirrhosis in patients with celiac disease","volume":"44","author":"Sorensen HT","year":"1999","journal-title":"Danish and Swedish cohort study"},{"key":"e_1_2_7_20_2","first-page":"401","article-title":"Autoimmune cholestatic liver disease in people with celiac disease","volume":"21","author":"Lawson A","year":"2005","journal-title":"a population-based study of their association"},{"key":"e_1_2_7_21_2","first-page":"120","article-title":"The association between primary biliary cirrhosis and celiac disease","volume":"42","author":"Kingham JGC","year":"1998","journal-title":"a study of relative prevalences"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199707000-00006"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-9-713"},{"key":"e_1_2_7_24_2","first-page":"71","article-title":"Primary sclerosing cholangitis with celiac sprue","volume":"22","author":"Fracassetti O","year":"1996","journal-title":"two cases"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026650118759"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.20047"},{"key":"e_1_2_7_27_2","first-page":"881","article-title":"Celiac disease in patients with severe liver disease","volume":"122","author":"Kaukinen K","year":"2002","journal-title":"gluten-free diet may reverse hepatic failure"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1993.tb01991.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91819-P"},{"key":"e_1_2_7_30_2","first-page":"286","article-title":"Prevalence of celiac disease in at\u2010risk and not\u2010at\u2010risk groups in the United States","volume":"163","author":"Fassano A","year":"2003","journal-title":"a large multicenter study"},{"key":"e_1_2_7_31_2","first-page":"910","article-title":"HLA susceptibility genes in celiac disease","volume":"105","author":"Sollid LM","year":"1993","journal-title":"genetic mapping and role in pathogenesis"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27620"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05471.x"},{"key":"e_1_2_7_34_2","first-page":"41","article-title":"Diagnostic criteria for celiac disease","volume":"17","author":"Murdock AM","year":"2005","journal-title":"time for change?"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.4.806"},{"key":"e_1_2_7_36_2","first-page":"83","article-title":"Significance of smooth muscle\/anti\u2010actin autoantibodies in celiac disease","volume":"35","author":"Pedreira S","year":"2005","journal-title":"Acta Gastroenterol Latinoam"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra033540"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01687.x"},{"key":"e_1_2_7_39_2","first-page":"1373","article-title":"Survival in refractory celiac disease and enteropathy associated T cell lymphoma","volume":"56","author":"Al\u2010Toma A","year":"2007","journal-title":"retrospective evaluation of single center experience"},{"key":"e_1_2_7_40_2","first-page":"374","article-title":"Malignancies and mortality in patients with celiac disease or dermatitis herpetiformis","volume":"38","author":"Viljamaa M","year":"2006","journal-title":"30-year population-based study"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-031104"},{"key":"e_1_2_7_42_2","first-page":"54","article-title":"Malignant lymphomas in celiac disease","volume":"54","author":"Smedby KE","year":"2005","journal-title":"evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma"},{"key":"e_1_2_7_43_2","first-page":"244","article-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients","volume":"79","author":"Ghobrial IM","year":"2005","journal-title":"are they two different diseases?"},{"key":"e_1_2_7_44_2","first-page":"362","article-title":"Prevalence and clinical features of selective immunoglobulin A deficiency in celiac disease","volume":"42","author":"Cataldo F","year":"1998","journal-title":"an Italian multicentre study"},{"key":"e_1_2_7_45_2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/CDLI.7.2.192-196.2000","article-title":"Immunoglobulin A (IgA) deficiency and alternative celiac disease\u2010associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing","volume":"7","author":"Prince HE","year":"2000","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2008.01681.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2008.01681.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T17:15:03Z","timestamp":1697303703000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2008.01681.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,12]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1478-3231.2008.01681.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01681.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,12]]}}}